Description
Each vial contains 60mg of highly pure Tirzepatide.
Tirzepatide is a dual receptor agonist that targets both GLP-1 and GIP receptors to support blood sugar regulation and weight management. By activating two complementary metabolic pathways, it helps reduce appetite, improve insulin response, and promote body fat loss.
Compared with GLP-1–only therapies such as semaglutide, tirzepatide has demonstrated greater weight loss and metabolic benefits in clinical studies.
Reconstitution
Add 3mL of bacteriostatic water to get a solution that is 20mg/mL, such that every 0.1mL (10 units on an insulin syringe) is equal to 2mg of Tirzepatide.
